tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Nathan Rich, 28 are a SELL (21.21%), 54 are a BUY (40.91%), 50 are a HOLD (37.88%).
Analyst Nathan Rich, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 71.59% that have a potential upside of 21.25% achieved within 144 days.
Nathan Rich’s has documented 252 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on OSCR, Oscar Health at 09-May-2024.
Analyst best performing recommendations are on OSCR (OSCAR HEALTH).
The best stock recommendation documented was for XRAY (DENTSPLY SIRONA) at 12/12/2023. The price target of $32 was fulfilled within 1 day with a profit of $1.01 (3.26%) receiving and performance score of 32.59.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$22
$1.01 (4.81%)
2 years 10 months 16 days ago
(13-Jun-2022)
3/4 (75%)
$1.33 (6.43%)
299
Buy
$21
$0.01 (0.05%)
$26
2 years 11 months 3 days ago
(26-May-2022)
0/4 (0%)
$0.3 (1.45%)
Hold
2 years 11 months 6 days ago
(23-May-2022)
1/3 (33.33%)
$7.54 (38.75%)
337
Buy
$21
$0.01 (0.05%)
2 years 11 months 6 days ago
(23-May-2022)
1/2 (50%)
$1.3 (6.60%)
54
Hold
$22
2 years 11 months 6 days ago
(23-May-2022)
0/2 (0%)
$6.55 (42.39%)
What Year was the first public recommendation made by Nathan Rich?
